Drug screening identifies Src/Abl inhibitor dasatinib as suppressor of IL-23 signaling in skin inflammation
Open Access
- 9 March 2026
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 158 (1) , 164-181
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Centro de Biología Molecular Severo Ochoa
- Centro Nacional de Biotecnología
This publication has 59 references indexed in Scilit:
- More TOR: The expanding role of mTOR in regulating immune responsesImmunity, 2025
- Interleukin 23 receptor: Expression and regulation in immune cellsEuropean Journal of Immunology, 2023
- Differential Roles of the mTOR-STAT3 Signaling in Dermal γδ T Cell Effector Function in Skin InflammationCell Reports, 2019
- Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin InflammationCell Reports, 2018
- Phosphoproteomic Analyses of Interleukin 2 Signaling Reveal Integrated JAK Kinase-Dependent and -Independent Networks in CD8 + T CellsImmunity, 2016
- The 3 major types of innate and adaptive cell-mediated effector immunityJournal of Allergy and Clinical Immunology, 2015
- Mechanically activated fyn utilizes mTORC2 to regulate RhoA and adipogenesis in mesenchymal stem cellsStem Cells, 2013
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin InflammationImmunity, 2011
- Interleukin-1 and IL-23 Induce Innate IL-17 Production from γδ T Cells, Amplifying Th17 Responses and AutoimmunityImmunity, 2009
- The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper CellsCell, 2006